Diagnosis, clinical importance and management of thyroid nodules

Main Article Content

Yu. Korsak
L. Nykytiuk

Abstract

A thyroid nodule is a discrete lesion within the thyroid gland that is radiologically distinct from the surrounding thyroid parenchyma. Thyroid nodules are prevalent in up to 68 % of randomly selected individuals in whom high resolution ultrasound is performed. The majority of nodules are benign. Thyroid nodules are the clinical manifestation of a myriad of pathologic processes. The use of ultrasound has dramatically reduced the number of patients who undergo surgery for nodules. Several risk scoring systems have been developed which aim to reduce interobserver variability and allow clinicians to make decisions regarding further workup and follow-up. The most useful of these is the Thyroid Imaging Reporting and Data System (TIRADS) classification. The six tier Bethesda scoring system has reduced variability and increased the ability to clinicians to guide patients with thyroid nodules. There is good correlation between cytology and histopathologic outcomes. A significant proportion of patients will however fall into an indeterminate category. The American Thyroid Association uses a different system based on an estimated risk of malignancy from centers that deal with a high volume of patients with thyroid nodules and malignancy. The availability of molecular markers enhanced with next generation sequencing technology and the expression classifier are added diagnostic aids that can help in management. However, these are not available in many countries and in resource limited settings. A pragmatic approach to the diagnosis of indeterminate nodules includes utilizing pre- and posttest probability, clinical acumen, correlation of ultrasound findings and expert opinion in some settings. Using this approach high risk patients can be appropriately chosen for surgery while relegating patients with lower risk to watchful follow-up.

Article Details

How to Cite
Korsak, Y., and L. Nykytiuk. “Diagnosis, Clinical Importance and Management of Thyroid Nodules”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 2, May 2021, pp. 155-9, doi:10.22141/2224-0721.17.2.2021.230570.
Section
Literature Review

References

Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016 Jan;26(1):1-133. doi:10.1089/thy.2015.0020.

Jiang H, Tian Y, Yan W, et al. The Prevalence of Thyroid Nodules and an Analysis of Related Lifestyle Factors in Beijing Communities. Int J Environ Res Public Health. 2016 Apr 22;13(4):442. doi:10.3390/ijerph13040442.

Dauksiene D, Petkeviciene J, Klumbiene J, et al. Factors Associated with the Prevalence of Thyroid Nodules and Goiter in Middle-Aged Euthyroid Subjects. Int J Endocrinol. 2017;2017:8401518. doi:10.1155/2017/8401518.

Song J, Zou SR, Guo CY, et al. Prevalence of Thyroid Nodules and Its Relationship with Iodine Status in Shanghai: a Population-based Study. Biomed Environ Sci. 2016 Jun;29(6):398-407. doi:10.3967/bes2016.052.

Bojunga J. Ultrasound of Thyroid Nodules. Ultraschall Med. 2018 Oct;39(5):488-511. doi:10.1055/a-0659-2350. (in German).

Li F, Pan D, Wu Y, et al. Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule. Diagn Cytopathol. 2019 Sep;47(9):881-889. doi:10.1002/dc.24248.

Liang XW, Cai YY, Yu JS, Liao JY, Chen ZY. Update on thyroid ultrasound: a narrative review from diagnostic criteria to artificial intelligence techniques. Chin Med J (Engl). 2019 Aug 20;132(16):1974-1982. doi:10.1097/CM9.0000000000000346.

Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. Epidemiology of Thyroid Cancer: A Review of the National Cancer Database, 2000-2013. Cureus. 2019 Feb 24;11(2):e4127. doi:10.7759/cureus.4127.

Du L, Wang Y, Sun X, et al. Thyroid cancer: trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer. 2018 Mar 15;18(1):291. doi:10.1186/s12885-018-4081-7.

Wang TS, Goffredo P, Sosa JA, Roman SA. Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg. 2014 Sep;38(9):2297-303. doi:10.1007/s00268-014-2602-3.

Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations. Int J Med Sci. 2019 Feb 28;16(3):450-460. doi:10.7150/ijms.29935.

Podda M, Saba A, Porru F, Reccia I, Pisanu A. Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors. World J Surg Oncol. 2015 Jun 4;13:193. doi:10.1186/s12957-015-0612-8.

Hahn SY, Shin JH, Oh YL, Kim TH, Lim Y, Choi JS. Role of Ultrasound in Predicting Tumor Invasiveness in Follicular Variant of Papillary Thyroid Carcinoma. Thyroid. 2017 Sep;27(9):1177-1184. doi:10.1089/thy.2016.0677.

Horvath E, Silva CF, Majlis S, et al. Prospective validation of the ultrasound based TIRADS (Thyroid Imaging Reporting And Data System) classification: results in surgically resected thyroid nodules. Eur Radiol. 2017 Jun;27(6):2619-2628. doi:10.1007/s00330-016-4605-y.

Periakaruppan G, Seshadri KG, Vignesh Krishna GM, Mandava R, Sai VPM, Rajendiran S. Correlation between Ultrasound-based TIRADS and Bethesda System for Reporting Thyroid-cytopathology: 2-year Experience at a Tertiary Care Center in India. Indian J Endocrinol Metab. 2018 Sep-Oct;22(5):651-655. doi:10.4103/ijem.IJEM_27_18.

Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY. Malignancy Risk Stratification of Thyroid Nodules: Comparison between the Thyroid Imaging Reporting and Data System and the 2014 American Thyroid Association Management Guidelines. Radiology. 2016 Mar;278(3):917-24. doi:10.1148/radiol.2015150056.

Baloch ZW, LiVolsi VA, Asa SL, et al. Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol. 2008 Jun;36(6):425-37. doi:10.1002/dc.20830.

Ahmadi S, Stang M, Jiang XS, Sosa JA. Hürthle cell carcinoma: current perspectives. Onco Targets Ther. 2016 Nov 7;9:6873-6884. doi:10.2147/OTT.S119980.

Teixeira GV, Chikota H, Teixeira T, Manfro G, Pai SI, Tufano RP. Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration. World J Surg. 2012 Jan;36(1):69-74. doi:10.1007/s00268-011-1336-8.

Jena A, Patnayak R, Prakash J, Sachan A, Suresh V, Lakshmi AY. Malignancy in solitary thyroid nodule: A clinicoradiopathological evaluation. Indian J Endocrinol Metab. 2015 Jul-Aug;19(4):498-503. doi:10.4103/2230-8210.159056.

Mitchell J, Yip L. Decision Making in Indeterminate Thyroid Nodules and the Role of Molecular Testing. Surg Clin North Am. 2019 Aug;99(4):587-598. doi:10.1016/j.suc.2019.04.002.

Ferrari SM, Fallahi P, Ruffilli I, et al. Molecular testing in the diagnosis of differentiated thyroid carcinomas. Gland Surg. 2018 Aug;7(Suppl 1):S19-S29. doi:10.21037/gs.2017.11.07.

Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012 Aug 23;367(8):705-15. doi:10.1056/NEJMoa1203208.

Marti JL, Avadhani V, Donatelli LA, et al. Wide Inter-institutional Variation in Performance of a Molecular Classifier for Indeterminate Thyroid Nodules. Ann Surg Oncol. 2015 Nov;22(12):3996-4001. doi:10.1245/s10434-015-4486-3.

Bongiovanni M, Crippa S, Baloch Z, et al. Comparison of 5-tiered and 6-tiered diagnostic systems for the reporting of thyroid cytopathology: a multi-institutional study. Cancer Cytopathol. 2012 Apr 25;120(2):117-25. doi:10.1002/cncy.20195.

Kim DW, Lee EJ, Jung SJ, Ryu JH, Kim YM. Role of sonographic diagnosis in managing Bethesda class III nodules. AJNR Am J Neuroradiol. 2011 Dec;32(11):2136-41. doi:10.3174/ajnr.A2686.

Ruhlmann M, Ruhlmann J, Görges R, et al. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid Surgeries. Thyroid. 2017 Oct;27(10):1300-1306. doi:10.1089/thy.2017.0026.

Cibas ES, Baloch ZW, Fellegara G, et al. A prospective assessment defining the limitations of thyroid nodule pathologic evaluation. Ann Intern Med. 2013 Sep 3;159(5):325-32. doi:10.7326/0003-4819-159-5-201309030-00006.

Harrell RM, Bimston DN. Surgical utility of Afirma: effects of high cancer prevalence and oncocytic cell types in patients with indeterminate thyroid cytology. Endocr Pract. 2014 Apr;20(4):364-9. doi:10.4158/EP13330.OR.

Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017 Mar;27(3):315-389. doi:10.1089/thy.2016.0457.

Agarwal S, Bychkov A, Jung CK, et al. The prevalence and surgical outcomes of Hürthle cell lesions in FNAs of the thyroid: A multi-institutional study in 6 Asian countries. Cancer Cytopathol. 2019 Mar;127(3):181-191. doi:10.1002/cncy.22101.

Kargi AY, Bustamante MP, Gulec S. Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making. Mol Imaging Radionucl Ther. 2017 Feb 9;26(Suppl 1):24-35. doi:10.4274/2017.26.suppl.04.

Frey MK, Kim SH, Bassett RY, et al. Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening. Gynecol Oncol. 2015 Nov;139(2):211-5. doi:10.1016/j.ygyno.2015.08.006.

Francis GL, Waguespack SG, Bauer AJ, et al; American Thyroid Association Guidelines Task Force. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015 Jul;25(7):716-59. doi:10.1089/thy.2014.0460.